Skip to main content
In Vivo logoLink to In Vivo
. 2020 Jul 3;34(4):2101–2105. doi: 10.21873/invivo.12014

Taller-than-wide Thyroid Nodules With Microcalcifications Are at High Risk of Malignancy

KONSTANTINOS D PAPAPOSTOLOU 1, CATHERINE C EVANGELOPOULOU 1, IOANNIS A IOANNIDIS 1, GEORGIA N KASSI 2,3, KONSTANTINOS S MORFAS 1, NIKOLAOS I KARAMINAS 1, HELEN J KARGA 1
PMCID: PMC7439909  PMID: 32606189

Abstract

Background/aim: Previous studies have shown that there may be a diversity in the ultrasonographic (US) features discriminating a malignant from a benign thyroid nodule. We determined the reliability of the specific nodule shape in combination with other US features in predicting thyroid carcinomas. Patients and Methods: This was a retrospective single-center study investigating the association of the morphological characteristics of nodular goiters from preoperative US and color Doppler images with malignancy based on pathology. Results: We evaluated 254 thyroid nodules (malignant, n=131) from 205 patients. Multivariable logistic regression analysis showed that taller-than-wide shape [odds ratio (OR)=25.3, 95% confidence interval (CI)=5.4-118.9; p<0.001], microcalcifications (OR=4.9, 95% CI=2.5-9.5; p<0.001), hypoechogenicity (OR=4.5; 95% CI=2-10.3; p<0.001) and size (OR=0.93; 95% CI=0.89-0.98; p=0.002) were independently associated with thyroid nodule malignancy. Additionally, we found a strong negative correlation between size and taller-than-wide shape of a thyroid nodule (r=−0.41, p<0.001). Conclusion: Among the important indicators of thyroid malignancy, taller-than-wide nodules with microcalcifications are most likely to be malignant.

Keywords: Thyroid, nodule, shape, microcalcifications, malignancy


Thyroid nodules are common lesions and are being diagnosed with increasing frequency (1,2). They are discovered either clinically or using sensitive imaging techniques (3). High-resolution ultrasonography (US) is a powerful tool for detecting thyroid lesions and identify nodules even with a size of a few millimeters (4,5). As the probability of a first diagnosed nodule being malignant is almost 7% (4), it is important for the clinician to be able to accurately distinguish between benign and malignant nodules in order to make the best clinical decision and minimize unnecessary surgical procedures.

Currently, US-guided fine-needle aspiration biopsy (FNAB) remains the gold standard within the diagnostic procedures in the workup of thyroid nodules. However, a significant number of cases give false-negative, nondiagnostic, indeterminate or suspicious results that are difficult for clinicians to assess (6-8). In this way, US and color Doppler standardized criteria are good diagnostic tools indicating position, size, margins, content, echogenicity, elasticity and vascular pattern of the nodule. For example, marked hypoechogenicity, microcalcifications, irregular margins, intranodular vascular images and low elasticity have been associated with malignancy (4,9-13). Studies have recently shown that a round appearance or a taller-than-wide shape of the nodule can be a US pattern suggestive of malignancy and recently the shape of a nodule has been added to the imaging criteria for suspicious lesions (12,14).

We aimed to investigate the association of the morphological characteristics of nodular goiters from preoperative US and color Doppler images with malignancy based on pathology.

Patients and Methods

Study design and patient population. This was a retrospective, single-center, cross-sectional study. We included patients with a nodular goiter who underwent routine preoperative US followed by total thyroidectomy between January 2012 and December 2017. The medical records of these patients were reviewed for demographics and thyroid nodule imaging and pathology results. All conventional and power color Doppler US of thyroid nodules were performed using a 6-12 MHz linear array transducer, logic 7 (KPI Healthcare Inc. Yorba Linda, CA, USA). The US findings were re-evaluated and interpreted by two radiologists with more than 20-year experience who were blinded to the final pathology results. The mean length of time between US and thyroidectomy was 2 months. Regarding multinodular lesions, only nodules more than 6 mm were finally evaluated. The investigated US features of the thyroid nodules included taller-than-wide shape (defined as an anteroposterior to transverse diameter ratio ≥1 in the axial plane), hypoechogenicity, microcalcifications (defined as ≤1 mm), irregular margins and intranodular vascularity. The study was approved by the Institutional Scientific Committee (00/16.10.2017).

Statistical analysis. Descriptive statistics are reported as the median and interquartile range (IQR) for continuous variables, and frequency and percentage for categorical variables. Continuous variables were compared using the Mann-Whitney U-test, while discrete variables were compared using the chi-square or Fisher's exact test, as appropriate. Univariate and multivariable logistic regression analyses were performed to determine the independent effects of sonographic variables associated with thyroid nodule malignancy using the Wald backward-selection method. Only statistically significant variables (p<0.05) from univariable analysis were entered the multivariable analysis. A receiver operating characteristic curve analysis was performed to assess the diagnostic performance of the US features distinguishing benign from malignant thyroid nodules. Correlation between nodule size and taller-than-wide shape was also analyzed by bivariate linear regression analysis. A p-value of less than 0.05 was considered as statistically significant. All analyses were performed using SPSS version 23.0 (IBM, Armonk, NY, USA).

Results

We evaluated 254 nodules from 205 patients (female, n=176) (Table I). Regarding the benign nodules (n=123) the diagnosis included nodular goiter (n=107), adenoma (n=5) and Hashimoto’s nodule (n=11), while the great majority of malignant nodules were papillary carcinomas (n=129) and only two were follicular carcinomas.

Table I. Baseline characteristics of the study cohort.

graphic file with name in_vivo-34-2102-i0001.jpg

IQR: Interquartile range

Univariate and multivariate logistic regression analyses are shown in Table II. Size [odds ratio (OR)=0.93, 95% confidence interval (CI)=0.89-0.98; p=0.002], taller-than-wide shape (OR=25.3; 95% CI=5.4-118.9; p<0.001), microcalcifications (OR=4.9, 95% CI=2.5-9.5; p<0.001), hypoechogenicity (OR=4.5, 95% CI=2-10.3; p<0.001) of thyroid nodules were the only variables independently associated with thyroid malignancy (Table II). Taller-than-wide shape compared to the other US features demonstrated the highest specificity, at 98%, for distinguishing malignant from benign thyroid nodules (Table III), reaching 100% when combined with the presence of microcalcifications (data not shown). Moreover, we found a strong negative linear correlation between the taller-than-wide shape and the size of the nodules, r=−0.41, p<0.001 (Figure 1).

Table II. Univariate and multivariate logistic regression analysis of ultrasonographic features of thyroid nodules associated with malignancy.

graphic file with name in_vivo-34-2103-i0001.jpg

OR: Odds ratio; CI: confidence interval

Table III. Diagnostic performance of ultrasonographic (US) features distinguishing malignant from benign thyroid nodules.

graphic file with name in_vivo-34-2103-i0002.jpg

AUC: Area under the receiver operating characteristics curve; CI: confidence interval; PPV: positive predictive value; NPV: negative predictive value; SN: sensitivity; SP: specificity

Figure 1. Correlation between thyroid nodule size and taller-than-wide shape [anteroposterior to transverse (AP:T) diameter ratio].

Figure 1

Discussion

This study indicates that in a clinical sample of patients with nodular goiters referred to our center, the majority of nodules with papillary carcinomas had a taller-than-wide shape, significantly higher than that of benign. Additionally, a significant number of carcinomas had micro-calcifications, but the most important finding was the coexistence of micro-calcifications in nodules with a taller-than-wide shape which represented the one third of our malignant nodules. None of the benign nodules with taller-than-wide shape had microcalcifications, increasing the specificity to 100%.

From the results of multiple studies is suggested that none individual US feature can accurately discriminate a malignant nodule and US alone cannot be used for the decision of surgical intervention (15-17). Furthermore, the Thyroid Imaging Reporting and Data System, which is applied primarily to exclude a thyroid malignant lesion, until now is not widely accepted to allow the clinicians for a proper therapeutic decision (18). Again, many studies evaluated the US findings by comparison with the cytological results after FNAB (16-18) but several factors can affect the diagnostic accuracy of FNAB, such as the experience of physicians in its performance, sampling error, non-diagnostic reports or cytological atypia of undetermined significance (19).

In several studies, the main suspicious features indicating thyroid malignancy were found to have different diagnostic power among different cohorts, as demonstrated from the ORs in multivariate analysis (17,20,21). For example, Liu et al. (20) and Moon et al. (21) found that microcalcifications were a stronger predictor of papillary carcinoma among other US features, following by nodule shape. Additionally, Capelli et al. reported an OR for malignant nodules of 8.6 for those with taller-than-wide shape (17).

In the current work, hypoechoic nodules, nodules with ill-defined margins, or those with intranodular vascularity had a high OR for malignancy but the highest OR was found for nodules with macrocalcifications and those nodules with taller-than-wide shape. In our cases, taller-than-wide shape, hypoechogenecity and microcalcifications were the most important factors predicting malignancy in multivariate regression analysis. Taller-than-wide nodule shape had a much higher OR than microcalcifications (33.8 vs. 6.7), whereas intranodular vascularity or ill-defined margins were not enough to determine a high risk of malignancy, as previously described (22). This was confirmed by the AUCs which are also used to evaluate the diagnostic accuracy. The AUCs of shape, microcalcifications and the combination of both were 0.671, 0.721 and 0.649 respectively, demonstrating relatively good accuracy, showing the combination also to be as useful as the shape or the presence of microcalcifications alone in predicting malignancy. It is known that the coexistence of two or more highly suspicious US criteria greatly increases the potential risk for nodules being malignant (17,23). In our work, the combination of microcalcifications and taller-than-wide shape was an independent predictor of malignancy and although the sensitivity was only approximately 30%, the specificity was 100%, since none of the benign nodules with taller-than-wide shape were found to have microcalcifications. This means that the coexistence of microcalcifications in taller-than-wide nodules provides strong evidence of malignancy, although the absence of this profile cannot exclude malignancy.

It should also be pointed out that marked hypoechogenecity was common in our malignant nodules, with an OR of 6.5, higher than previously reported (24) indicating an increased risk of malignancy, whereas intranodular vascularity or ill-defined margins were adequate for determining a high risk of malignancy. When hypoechogenecity was evaluated in combination with microcalcifications and with the shape, our results showed no improvement of sensitivity or higher AUC (data not shown). In our study, nodules with taller-than-wide shape or shape combined with microcalcifications were the best predictors of malignancy.

It should also be noted that the size of malignant nodules was significantly lower than that of benign ones, reflecting the strong negative correlation between the nodule size and taller-than-wide shape. This might mean that smaller nodules with taller-than-wide shape are more often malignant than larger ones. Previous studies have examined the correlation between malignancy and nodule size (25,26). These studies included large nodules (>3 cm) and size correlated with the FNAB results and other US findings but not with the shape as evaluated in our study. Hammad et al. proposed a cut-off point of 6 cm where the incidence of carcinoma decreases with increasing size of thyroid nodules (26). The anteroposterior nodule diameter might be suitable for assessing thyroid malignancy in microcarcinomas, with a critical value >0.7 cm (12).

In our study, one limitation included a lack of a large number of nodules more than 4 cm in size. The explanation for this is that clinicians often recommend thyroid US to their patients and thyroid cancer is increasingly discovered at an early stage (27). A strength of our study is that there were final pathological results for all nodules after thyroidectomy and there was no selection bias since all patients who had undergone operations were included, without exception, and this explains how the potential malignancy rate was higher in comparison with the non-operated on nodules. On the other hand, the main limitation of the study was the relatively small number of nodules included and that it was a single-center study.

In conclusion, the current study emphasizes that among the important indicators of thyroid malignancy, taller-than-wide nodules with microcalcifications are most likely to be malignant and surgical treatment should be considered for these patients. The strong negative correlation between thyroid nodule size and the taller-than-wide shape (potential malignancy) needs additional studies including more larger nodules.

Conflicts of Interest

The Authors declare no conflicts of interest in regard to this study.

Authors’ Contributions

K.D.P: study concept and design, data analysis and interpretation, statistical analysis and article writing; H.J.K: study concept design, data analysis and interpretation and critical revision of the article; C.C.E., I.A.I., K.S.M., N.I.K.: data acquisition and interpretation and critical revision of the article; G.N.K.: statistical analysis and critical revision of the article.

References

  • 1.Moon JH, Hyun MK, Lee JY, Shim JI, Kim TH, Choi HS, Ahn HY, Kim KW, Park DJ, Park YJ, Yi KH. Prevalence of thyroid nodules and their associated clinical parameters: a large-scale, multicenter-based health checkup study. Korean J Intern Med. 2017;32:536–547. doi: 10.3904/kjim.2015.273. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Kilfoy BA, Zheng T, Holford TR, Han X, Ward MH, Sjodin A, Zhang Y, Bai Y, Zhu C, Guo GL, Rothman N, Zhang Y. International patterns and trends in thyroid cancer incidence 1973-2002. Cancer Causes Control. 2009;20:525–531. doi: 10.1007/s10552-008-9260-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Marqusee E, Benson CB, Frater MC, Doubilet PM, Larsen PR, Cibas ES, Mandel SJ. Usefulness of ultrasonography in the management of nodular thyroid disease. Ann Intern Med. 2000;133:696–700. doi: 10.7326/0003-4819-133-9-200011070-00011. [DOI] [PubMed] [Google Scholar]
  • 4.Rago T, Vitti P, Chiovato L, Mazzeo S, De Liperi A, Miccoli P, Viacava P, Bogazzi F, Martino E, Pinchera A. Role of conventional ultrasonography and color flow-doppler sonography in predicting malignancy in “cold” thyroid nodules. Eur J Endocrinol. 1998;138:41–46. doi: 10.1530/eje.0.1380041. [DOI] [PubMed] [Google Scholar]
  • 5.Frates MC, Benson CB, Doubilet PM, Kunreuther E, Contreras M, Cibas ES, Orcutt J, Moore FD Jr, Larsen PR, Marqusee E, Alexander EK. Prevalence and distribution of carcinoma in patients with solitary and multiple thyroid nodules on sonography. J Clin Endocrinol Metab. 2006;91:3411–1417. doi: 10.1210/jc.2006-0690. [DOI] [PubMed] [Google Scholar]
  • 6.Paajanen I, Metso S, Jaatinen P, Kholová I. Thyroid FNA diagnosis in a real-life setting: Experience of the implementation of the Bethesda system in Finland. Cytopathology. 2017;29:189–195. doi: 10.1111/cyt.12513. [DOI] [PubMed] [Google Scholar]
  • 7.Yeh MW, Demicran O, Ituarte P, Clark OH. False-negative fine needle aspiration cytology results delay treatment and adversely affect outcome in patients with thyroid carcinoma. Thyroid. 2004;14:207–215. doi: 10.1089/105072504773297885. [DOI] [PubMed] [Google Scholar]
  • 8.Le AR, Thompson GW, Hoyt BJ. Thyroid fine-needle aspiration biopsy: an evaluation of its utility in a community setting. J Otolarynol Head Neck Surg. 2015;44:12. doi: 10.1186/s40463-015-0063-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Wang Y, Nie F, Liu T, Yang D, Li Q, Li J, Song A. Revised value of contrast-enhanced ultrasound for solid hypo-echoic thyroid nodules graded with thyroid imaging reporting and data system. Ultrasound Med Biol. 2018;44:930–940. doi: 10.1016/j.ultrasmedbio.2017.12.018. [DOI] [PubMed] [Google Scholar]
  • 10.Park SH, Kim SJ, Kim EK Kim MJ, Son EJ, Kwak JY. Interobserver agreement in assessing the sonographic and elastographic features of malignant thyroid nodules. Am J Roentgenol. 2009;193:416–423. doi: 10.2214/AJR.09.2541. [DOI] [PubMed] [Google Scholar]
  • 11.Moon HJ, Kwak JY, Kim MJ, Son EJ, Kim EK. Can vascularity at power Doppler US help predict thyroid malignancy. Radiology. 2010;255:260–269. doi: 10.1148/radiol.09091284. [DOI] [PubMed] [Google Scholar]
  • 12.Huang K, Gao N, Zhai Q, Bian D, Wang D, Wang X. The anteroposterior diameter of nodules in the risk assessment of papillary thyroid microcarcinoma. Medicine. 2018;97:e9712. doi: 10.1097/MD.0000000000009712. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Rago T, Scutari M, Loiacono V, Santini F, Tonacchera M, Torregrossa L, Giannini R, Borrelli N, Proietti A, Basolo F, Miccoli P, Piaggi P, Latrofa F, Vitti P. Low elasticity of thyroid nodules on ultrasound elastography is correlated with malignancy, degree of fibrosis and high expression of galectin-3 and fibronectin-1. Thyroid. 2017;27:103–110. doi: 10.1089/thy.2016.0341. [DOI] [PubMed] [Google Scholar]
  • 14.Liu J, Zheng D, Liq Q, Tang X, Luo Z, Yuan Z, Gao L, Zhao J. A predictive model of thyroid malignancy using clinical, biochemical and sonographic parameters for patients in a multi-center setting. BMC Endocr Disord. 2018;18:17. doi: 10.1186/s12902-018-0241-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Na DG, Baek JH, Sung JY, Kim JH, Kim JK, Choi YJ, Seo H. Thyroid reporting and data system risk stratification of thyroid nodules: Categorization based on solidity and echogenicity. Thyroid. 2016;4:562–572. doi: 10.1089/thy.2015.0460. [DOI] [PubMed] [Google Scholar]
  • 16.Eun NL, Yoo MR, Gweon HM, Park AY, Kim JA, Youk JH, Moon HJ, Chang HS, Son EJ. Thyroid nodules with nondiagnostic results on repeat fine-needle aspiration biopsy: which nodules should be considered for repeat biopsy or surgery rather than follow-up. Ultrasonography. 2016;35:234–243. doi: 10.14366/usg.15079. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Cappelli C, Castellano M, Pirola I, Gandossi E, De Martino E, Cumetti D, Agosti B, Rosei EA. Thyroid nodule shape suggests malignancy. Eur J Endocrinol. 2006;155:27–31. doi: 10.1530/eje.1.02177. [DOI] [PubMed] [Google Scholar]
  • 18.Peccin S, de Castsro JA, Furlanetto TW, Furtado AP, Brasil BA, Czepielewski MA. Ultrasonography: is it useful in the diagnosis in thyroid nodules. J Endocrinol Invest. 2002;25:39–43. doi: 10.1007/bf03343959. [DOI] [PubMed] [Google Scholar]
  • 19.Kim HG, Moon HJ, Kwak JY, Kim EK. Diagnostic accuracy of the ultrasonographic features for subcentimeter thyroid nodules suggested by the revised American Thyroid Association guidelines. Thyroid. 2013;23:1583–1589. doi: 10.1089/thy.2012.0586. [DOI] [PubMed] [Google Scholar]
  • 20.Liu Y, Wu H, Zhou Q, Gou J, Xu J, Liu Y, Chen Q. Diagnostic value of conventional ultrasound combined with contrast-enhanced ultrasonography in thyroid imaging reporting and data system (TI-RADS) 3 and 4 thyroid micronodules. Med Sci Monit. 2016;22:3086–3094. doi: 10.12659/msm.897011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Moon WJ, Jung SL, Lee JH, Na DG, Baek JH, Lee YH, Kim J, Kim HS, Byun JS, Lee DH Benign, malignant thyroid nodules. US differentiation –multicenter retrospective study. Radiology. 2008;247:762–770. doi: 10.1148/radiol.2473070944. [DOI] [PubMed] [Google Scholar]
  • 22.Remonti LR, Kramer CK, Leitao CB, Leitão CB, Pinto LC, Gross JL. Thyroid ultrsound features and risk of carcinoma: A systematic review and meta-analysis of observational studies. Thyroid. 2015;5:538–550. doi: 10.1089/thy.2014.0353. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Papini E, Guglielmi R, Bianchini A, Crescenzi A, Taccogna S, Nardi F, Panunzi C, Rinaldi R, Toscano V, Pacella CM. Risk of malignancy in nonpalpable thyroid nodules: predictive value of ultrasound and color –Doppler features. J Clin Endocrinol Metab. 2002;87:1941–1946. doi: 10.1210/jcem.87.5.8504. [DOI] [PubMed] [Google Scholar]
  • 24.Xue E, Zheng M, Zhang S, Huang L, Qian Q, Huang Y. Ultrasonography-based classification and reporting system for the malignant risk of thyroid nodules. J Nippon Med Sch. 2017;84:118–124. doi: 10.1272/jnms.84.118. [DOI] [PubMed] [Google Scholar]
  • 25.Kamran SC, Marqusee E, Kim MI, Frates MC, Ritner J, Peters H, Benson CB, Doubilet PM, Cibas ES, Barletta J, Cho N, Gawande A, Ruan D, Moore FD Jr., Pou K, Larsen PR, Alexander EK. Thyroid nodules size and prediction of cancer. J Clin Endocrinol Metab. 2013;98:564–570. doi: 10.1210/jc.2012-2968. [DOI] [PubMed] [Google Scholar]
  • 26.Hammad AY, Noureldine SI, Hu T, Ibrahim Y, Masoodi HM, Kandil E. A meta-analysis examining the independent association between thyroid nodule size and malignancy. Gland Surg. 2016;5:312–317. doi: 10.21037/gs.2015.11.05. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Karga H, Mavroudis K, Giagourta I, Triantaphyllopoulou M, Ktena V, Kassi G, Veloutsou H, Papapetrou P. Changes in TNM stage reoperation and 131-I ablation rate during the use of newer methods for the preoperative diagnosis of differentiated thyroid carcinoma. Clin Endocrinol. 2012;76:289–296. doi: 10.1111/j.1365-2265.2011.04199.x. [DOI] [PubMed] [Google Scholar]

Articles from In Vivo are provided here courtesy of International Institute of Anticancer Research

RESOURCES